# Vimpat

NDC: 0131-1810
Generic name: lacosamide
Labeler / Manufacturer: UCB, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION
Routes: INTRAVENOUS
Marketing started: 20090526

FDA application: NDA022254

## Active ingredients

- LACOSAMIDE: 10 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0131-1810"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0131-1810
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=9e79b42c-38a3-4b2c-a196-a5a1948250e2